Personal information

Activities

Collapse all

Funding (3)

Development of new Acadesine derivatives, preclinical and clinical evaluation in cancerology. Study in MyeloDysplastic Syndromes

2012-09-03 to 2015-09-03 | Grant
French National Cancer Institute (Boulogne-Billancourt, FR)
URL: https://grants.uberresearch.com/501100006364/INCa_5669/Development-of-new-Acadesine-derivatives-preclinical-and-clinical-evaluation-in-cancerology-Study-in-MyeloDysplastic-Syndromes
GRANT_NUMBER:

INCa_DGOS_5669
Source: Self-asserted source
Patrick AUBERGER via DimensionsWizard

Targeting cancer cell metabolism for cancer therapy

2010-11-11 to 2013-11-10 | Grant
French National Cancer Institute (Boulogne-Billancourt, FR)
URL: https://grants.uberresearch.com/501100006364/INCa_2649/Targeting-cancer-cell-metabolism-for-cancer-therapy
GRANT_NUMBER:

INCa_2649
Source: Self-asserted source
Patrick AUBERGER via DimensionsWizard

Deciphering cell death pathways in myelodysplastic syndromes cell line exposed to Azacitidine

2009-10-05 to 2011-10-04 | Grant
French National Cancer Institute (Boulogne-Billancourt, FR)
URL: https://grants.uberresearch.com/501100006364/INCa_1470/Deciphering-cell-death-pathways-in-myelodysplastic-syndromes-cell-line-exposed-to-Azacitidine
GRANT_NUMBER:

INCa_1470
Source: Self-asserted source
Patrick AUBERGER via DimensionsWizard

Peer review (4 reviews for 3 publications/grants)

Review activity for Cancers. (1)
Review activity for Cell death and disease. (2)
Review activity for Drug resistance updates. (1)
How many people are using ORCID?